Patent · US Active

BCMA antigen binding proteins

US9243058B2 · kind B2 · utility

39Cited by
0References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2013
Grant dateJan 26, 2016
Priority date
Expiry dateDec 5, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.